• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA25 A.PRECHAMBER; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA25 A.PRECHAMBER; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX442T
Device Problems Obstruction of Flow (2423); Blocked Connection (2888)
Patient Problem Failure of Implant (1924)
Event Date 11/09/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional,"10m po valve is blocked.Explanted.".
 
Manufacturer Narrative
Investigation: visual inspection: a deformation of the outer housing of the progav 2.0 valve was observed through the visual inspection.No significant deformations or damage of the shunt assistant valve was detected.Permeability test: a permeability test has indicated that the shunt assistant has a blockage and the progav 2.0 valve is permeable.Adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and braking force is within the given tolerances.Results: finally, we have dismantled the valves.Inside the progav 2.0 valve we found slight visible deposits (likely protein).No visible deposits were observed inside the shunt assistant valve.Based on our investigation, we confirm the presence of occlusion in the shunt assistant valve.Even a small amount of non-visible blood protein can lead to temporary blockage and could be responsible for the suspected malfunction.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS PED.W/SA25 A.PRECHAMBER
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8148971
MDR Text Key129873245
Report Number3004721439-2018-00291
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 03/08/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/05/2022
Device Model NumberFX442T
Device Catalogue NumberFX442T
Device Lot Number20034174
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/16/2018
Distributor Facility Aware Date02/25/2019
Device Age1 YR
Initial Date Manufacturer Received 11/19/2018
Initial Date FDA Received12/10/2018
Supplement Dates Manufacturer Received02/25/2019
Supplement Dates FDA Received03/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 YR
Patient Weight20
-
-